Which absorbable suture belongs on your surgical tray? For procurement teams and clinical educators, the answer depends on how a material degrades, how fast it loses strength, and how much clinical evidence sits behind it. Three polymer families dominate the conversation: PGA (polyglycolic acid), PLA (polylactic acid, including polyglactin 910), and PHA (polyhydroxyalkanoates). This guide compares how each works, where each stands clinically, and what to ask before adding one to your formulary.
How absorbable sutures work
Absorbable sutures hold wound edges together long enough for tissue to heal, then disappear. Degradation happens primarily through hydrolysis: water in the tissue cleaves the polymer’s ester bonds, and the fragments are metabolized and cleared. Enzymes can accelerate the process in some materials. Two numbers matter for planning — how long the suture keeps tensile strength, and how long until complete absorption. Both depend on polymer chemistry. The Pillai and Sharma review of absorbable polymeric sutures (Journal of Biomaterials Applications, 2010) remains a dependable reference for these fundamentals.
PGA: the original synthetic absorbable
Polyglycolic acid launched the modern absorbable suture era with Dexon in the 1970s. This homopolymer of glycolic acid degrades quickly: most PGA sutures retain useful tensile strength for roughly two to three weeks, with complete absorption typically reached within 60 to 90 days. The trade-off is handling. PGA is stiff relative to newer materials, which makes it less forgiving at the knot, and braided forms can drag through tissue. It remains widely used where rapid absorption is desirable, though many surgeons reach for coated or copolymer versions for softer performance.
PLA and polyglactin 910: the clinical workhorse
Polylactic acid is the lactide-based partner in the absorbable suture story. Pure PLA homopolymers degrade slowly — over months to more than a year depending on stereochemistry — which suits long-healing tissues but is excessive for routine closures. The material that made the family famous is polyglactin 910 (Vicryl): a braided copolymer of 90% glycolide and 10% L-lactide introduced in the 1970s. It retains roughly half its tensile strength at three weeks, absorbs completely in approximately 56 to 70 days, and handles predictably. Decades of use across general, gynecologic, and orthopedic surgery make it the reference point any new absorbable thread must match. Our guide to PLA in absorbable sutures covers the chemistry in detail.
PHA: the research-stage candidate
Polyhydroxyalkanoates are a family of polyesters produced by microorganisms. Bacteria store PHA granules as energy reserves, and manufacturers harvest and spin those granules into fibers. The properties are attractive on paper: PHA is flexible and tough, degrades by hydrolysis into natural metabolites, and shows favorable biocompatibility in cell and animal studies, per the MDPI Polymers review of PHA in tissue engineering. The material is also home-compostable, which matters to sustainability-focused facilities. Clinical adoption is another story. With the notable exception of poly-4-hydroxybutyrate (P4HB), a PHA-family polymer behind some cleared absorbable products and the subject of ongoing fiber-processing research, most PHA-based absorbable threads remain in research and early development rather than routine OR inventory. Treat PHA as a promising pipeline material, not a current standard. Our explainer on PHA sutures tracks the research landscape.
PGA vs PLA vs PHA at a glance
| Factor | PGA | PLA / polyglactin 910 | PHA |
|---|---|---|---|
| Typical absorption | 60–90 days | ~56–70 days (polyglactin 910) | Varies by type; still being characterized |
| Strength retention | ~2–3 weeks | ~50% at 3 weeks | Under study; type-dependent |
| Flexibility and handling | Stiff; braided or monofilament | Braided; predictable handling | Flexible and tough |
| Clinical status | Established standard since the 1970s | Established standard; broad use | Research and early development; P4HB niche products cleared |
Biocompatibility and the ISO 10993 framework
Biocompatibility is the gate before any new suture material reaches clinical use. ISO 10993 is the framework used to evaluate medical devices: cytotoxicity, sensitization, irritation, systemic toxicity, and degradation products are assessed in staged tests. PGA and polyglactin 910 carry decades of ISO-aligned testing and real-world data. PHA materials have shown encouraging biocompatibility in published studies, but the full ISO 10993 dossier — and the clinical evidence — is still being built for most PHA threads. When a supplier pitches an absorbable suture, ask which ISO 10993 tests were performed and request strength-retention data, not just the polymer name.
Choose based on evidence and timelines. For routine absorbable closure today, polyglactin 910 and PGA remain the dependable options with predictable absorption and strength profiles. PHA is the material to watch — flexible, biocompatible, and compostable, but still maturing from the lab into clinical products. The practical question for procurement is not which polymer is newest, but which degradation and strength profile matches the procedure — and which has the data to back it. CliniEco’s guides track both sides: the PHA suture research explainer and the PLA suture guide. Bring both to your next suture review, and the decision gets easier.
Facilities shifting toward greener purchasing often start with high-volume disposables. CliniEco offers PLA biodegradable underpads and PLA bed sheets as a practical, certified starting point for Canadian clinics and long-term care homes.
Sutures arrive sterile, but reusable trays do not: a five-pack trial of biological indicators covers a month of daily monitoring.
Related Reading
- Quat vs Bleach vs Alcohol Wipes: Disinfectant Chemistry Explained
- Wound Dressing Basics: Gauze, ABD Pads & Bandages Explained
- ISO 11140-1 Explained: Chemical Indicator Classes for Sterilization
- explore our eco-friendly and sustainable product guides
- family practice clinic supplies
Frequently Asked Questions
How long does a PGA suture keep its strength?
Roughly two to three weeks. Polyglycolic acid degrades quickly: most PGA sutures retain useful tensile strength for about two to three weeks and are completely absorbed within 60 to 90 days, which is why the material still suits closures where rapid absorption is desirable.
What is the difference between PLA and polyglactin 910?
Polyglactin 910 is a copolymer of 90% glycolide and 10% L-lactide, so PLA supplies the lactide half. Pure PLA homopolymers degrade slowly, over months to more than a year, while polyglactin 910 retains about half its tensile strength at three weeks and absorbs in roughly 56 to 70 days.
Are PHA sutures available for routine surgery?
Not as a standard formulary item. Most PHA-based absorbable threads remain in research and early development; the exception is the PHA-family polymer P4HB, which sits behind some cleared absorbable products and continues to be studied for fiber processing. Treat PHA as a pipeline material when you plan inventory.
What has to be demonstrated before a new suture material is adopted?
Biocompatibility comes first. New materials are evaluated under the ISO 10993 framework for cytotoxicity, sensitization and irritation before clinical use, and procurement teams should ask for that test documentation alongside absorption and strength-retention data.
Last updated: September 2026. CliniEco Medical is a licensed medical device establishment (MDEL #35334).
0 commentaire